Riverhead Capital Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $358K | Buy |
1,310
+173
| +15% | +$47.3K | 0.01% | 872 |
|
|
2019
Q2 | $607K | Sell |
1,137
-381
| -25% | -$203K | 0.02% | 655 |
|
|
2019
Q1 | $765K | Sell |
1,518
-3,591
| -70% | -$1.81M | 0.03% | 542 |
|
|
2018
Q4 | $2.52M | Buy |
5,109
+964
| +23% | +$475K | 0.11% | 240 |
|
|
2018
Q3 | $3.79M | Buy |
4,145
+3,669
| +771% | +$3.35M | 0.14% | 199 |
|
|
2018
Q2 | $348K | Buy |
476
+337
| +242% | +$246K | 0.01% | 830 |
|
|
2018
Q1 | $222K | Sell |
139
-673
| -83% | -$1.07M | 0.01% | 1015 |
|
|
2017
Q4 | $727K | Buy |
812
+140
| +21% | +$125K | 0.03% | 524 |
|
|
2017
Q3 | $242K | Buy |
672
+88
| +15% | +$31.7K | 0.01% | 899 |
|
|
2017
Q2 | $171K | Buy |
584
+257
| +79% | +$75.3K | 0.01% | 989 |
|
|
2017
Q1 | $115K | Buy |
327
+34
| +12% | +$12K | 0.01% | 939 |
|
|
2016
Q4 | $54K | Hold |
293
| – | – | ﹤0.01% | 1218 |
|
|
2016
Q3 | $76K | Sell |
293
-3,705
| -93% | -$961K | ﹤0.01% | 1015 |
|
|
2016
Q2 | $716K | Buy |
3,998
+2,121
| +113% | +$380K | 0.02% | 518 |
|
|
2016
Q1 | $387K | Sell |
1,877
-63
| -3% | -$13K | 0.01% | 988 |
|
|
2015
Q4 | $490K | Buy |
1,940
+1,333
| +220% | +$337K | 0.01% | 907 |
|
|
2015
Q3 | $100K | Buy |
+607
| New | +$100K | ﹤0.01% | 1088 |
|